Related Experiment Video

Updated: Jun 24, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

[Progress in the study of antitumor drug targeting on the Ras signaling pathway]

Yi-jing Zhu1, Feng-chao Jiang

  • 1School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|April 9, 2009
PubMed

Insights

The Ras signaling pathway drives tumor formation and growth. This review covers Ras protein, its targets, and inhibitors, aiding the development of new anticancer drugs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Context:

  • The Ras signaling pathway is integral to cellular processes, and its dysregulation is implicated in numerous cancers.
  • Targeting the Ras pathway is a significant focus in modern anticancer drug development.

Purpose:

  • To review the Ras protein, its associated molecular targets, and existing inhibitors within the signaling pathway.
  • To provide a foundational reference for researchers designing novel anticancer therapeutics.

Summary:

  • This paper synthesizes current knowledge on the Ras signaling pathway, a critical regulator of cell growth and a key player in tumorigenesis.
  • It details the structure and function of Ras proteins, explores key downstream targets, and discusses various classes of inhibitors that modulate pathway activity.

Impact:

  • Facilitates the rational design of next-generation anticancer drugs targeting the Ras pathway.
  • Contributes to a deeper understanding of oncogenic signaling and potential therapeutic interventions.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...